about
Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014Regulation of urinary bladder function by protein kinase C in physiology and pathophysiologyCajal-like interstitial cells as a novel target in detrusor overactivity treatment: true or myth?Urothelial signaling.Nervous network for lower urinary tract function.Emerging Families of Ion Channels Involved in Urinary Bladder Nociception.Obstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.NS19504: a novel BK channel activator with relaxing effect on bladder smooth muscle spontaneous phasic contractions.BK channel activators and their therapeutic perspectivesHydrogen sulfide plays a key role in the inhibitory neurotransmission to the pig intravesical ureter.Phasic contractions in urinary bladder from juvenile versus adult pigs.Bladder smooth muscle strip contractility as a method to evaluate lower urinary tract pharmacology.Pathophysiology and animal modeling of underactive bladder.Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery.Pulse Diode Laser Irradiation (830 nm) of Lumbosacral Spinal Roots Diminished Hyperreflexia-Induced by Acetic Acid or Prostaglandin E2 Infusion in Rat Urinary Bladder.Structural and functional changes in gap junctional intercellular communication in a rat model of overactive bladder syndrome induced by partial bladder outlet obstructionEfficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis.Original Research: Combined model of bladder detrusor smooth muscle and interstitial cells.Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.Effect of intraoperative paracetamol on catheter-related bladder discomfort: a prospective, randomized, double-blind study.Neurotrophins as regulators of urinary bladder function.Bladder function development and its urodynamic evaluation in neonates and infants less than 2 years old.Altered expression and modulation of the two-pore-domain (K2P) mechanogated potassium channel TREK-1 in overactive human detrusor.Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.Elevated steady-state bladder preload activates myosin phosphorylation: detrusor smooth muscle is a preload tension sensor.Low amplitude rhythmic contraction frequency in human detrusor strips correlates with phasic intravesical pressure waves.Pre- and post-junctional bradykinin B2 receptors regulate smooth muscle tension to the pig intravesical ureter.Urethral afferent signalling: role of 5-HT paraneurons.Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.Overactive Bladder Syndrome: Evaluation and Management.Spontaneous Contractile Activity of the Detrusor Muscle and Its Role in the Pathogenesis of Overactive Bladder Syndrome.Regulation of Spontaneous Contractions in Intact Rat Bladder Strips and the Effects of Hydrogen Peroxide.Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial.Investigation of the Syncytial Nature of Detrusor Smooth Muscle as a Determinant of Action Potential Shape
P2860
Q26766221-E317B671-66DC-488C-BA57-A739506AA5FFQ26780063-1F7682CE-9FFF-4173-A6D6-FDE9E3311D71Q26861452-5450E62D-7946-44A1-A9AD-993A7B6861E6Q30440958-260E4537-5F04-4B5B-B0FA-59B4C5FFC757Q33675230-66125A52-135D-4977-892B-49B127C74051Q33677969-2DB18A3F-66D7-4AFC-A059-9B6927CBE7A8Q34062449-FF88DC4E-DA57-451A-B646-7DBDE9BE6E08Q34125126-3FBAD977-FF36-4F45-BF71-C8CBC8EE44B5Q34311824-3D85C0A4-0C5C-440A-8651-2B6261D7808BQ34557568-17C878F6-5209-47F7-B132-1AECCF487605Q34629808-CE6BE2E9-894C-4228-8654-64642E3E8D52Q35618693-8EA28090-FCD3-44B1-9949-0A5F0236431EQ35747930-3EECEB7C-8033-4D97-878B-894B7F2C3AB9Q35814327-A35791A2-D296-4A75-8D8C-4E9E1D24A7D8Q35871117-69104565-8FD7-47FB-8BF7-338ECE562B02Q36047837-7A61CEDB-7F51-4684-8294-5CC8E4845EB7Q36245584-4C8E92BC-2504-499A-8005-7E42534C7325Q37265445-60F96B9E-EEE9-4933-B2D3-BF361329065EQ37589167-6081A59F-F8E9-4F27-89F0-2B90B9B8094CQ37638833-6E79174C-40ED-4182-8FAE-2D2E65377745Q38050405-E3847C59-CC47-4AF8-B04D-A6218CF9A846Q38208726-A7F3D3D1-895A-42F0-9921-449340AE8C04Q38679634-BB9F2935-D644-459E-ADA8-70BE6D127CB6Q42659058-CC6902E6-B27D-4495-952C-BF3BCAF68494Q44978891-740114C3-A827-4205-8096-0FDC09A23EC5Q45049691-5C60E5F7-CFCA-47DE-A23F-570B333DB504Q48045160-1C4850BA-0BB7-4E73-9B58-1307616E3E56Q50091420-00E40B49-19C7-49C7-A2BD-8C4C8A633D3DQ53026190-89AC7FD6-16E8-4D93-B8E1-6EAD73CC6AC2Q53945500-8F1736BD-C65A-47C0-B483-0E8DB5FAA7AEQ54527671-FD9226BC-A2F6-432D-9251-383968C5163EQ54982435-32ACF87E-91CC-42AE-986D-B469500536D5Q55386629-478AAAE3-DCDC-4C83-9586-90470F7D34FAQ57191816-03EC6377-E78A-4E0E-913E-21E9D5D72EA4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Detrusor myocyte activity and afferent signaling.
@en
Detrusor myocyte activity and afferent signaling.
@nl
type
label
Detrusor myocyte activity and afferent signaling.
@en
Detrusor myocyte activity and afferent signaling.
@nl
prefLabel
Detrusor myocyte activity and afferent signaling.
@en
Detrusor myocyte activity and afferent signaling.
@nl
P2860
P356
P1476
Detrusor myocyte activity and afferent signaling.
@en
P2093
Karl-Erik Andersson
P2860
P304
P356
10.1002/NAU.20784
P577
2010-01-01T00:00:00Z